Related Experiment Video

Updated: Aug 25, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

AII antagonists in hypertension, heart failure, and diabetic nephropathy: focus on losartan

Carlos Ferrario1, Abdelhamed I Abdelhamed, Michael Moore

  • 1Hypertension and Vascular Disease Center, Wake-Forest University School of Medicine, Winston-Salem, NC 27157, USA. cferrari@wfubmc.edu

Current Medical Research and Opinion
|March 18, 2004
PubMed

Insights

Angiotensin II antagonists (AIIAs) offer cardiovascular benefits beyond blood pressure control in hypertension, heart failure, and diabetic nephropathy. Emerging evidence suggests specific AIIAs like losartan may have unique pharmacological advantages.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Nephrology

Background:

  • Antihypertensive therapy aims to prevent cardiovascular complications, not solely normalize blood pressure.
  • Angiotensin II antagonists (AIIAs) have been investigated for their effects on clinical outcomes in various cardiovascular and renal conditions.
  • Recent trials focus on proven clinical endpoints rather than surrogate markers.

Purpose of the Study:

  • To review recent outcomes studies of AIIAs in patients with hypertension, heart failure, or diabetic nephropathy.
  • To examine potential molecular differences within the AIIA class and their clinical relevance.
  • To explore unique pharmacological properties of specific AIIAs, such as losartan.

Main Methods:

  • Review of recent clinical trials and outcomes studies involving AIIAs.
  • Analysis of data on cardiovascular and renal endpoints in patient populations.
  • Examination of emerging evidence on specific pharmacological effects of AIIAs.

Main Results:

  • AIIAs demonstrate benefits in preventing cardiovascular complications and improving outcomes in hypertension, heart failure, and diabetic nephropathy.
  • Specific AIIAs may offer distinct therapeutic advantages for certain patient groups.
  • Losartan shows potential for unique pharmacological benefits, including effects on uric acid, platelets, sexual dysfunction, and cognition.

Conclusions:

  • AIIAs provide significant clinical benefits beyond blood pressure reduction.
  • Molecular differences among AIIAs may explain observed outcome variations.
  • Further research is necessary to fully understand and clinically utilize the distinct properties of individual AIIAs.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...